TME	Tumor microenvironment
ICI	Immune checkpoint inhibitors
CTLA-4	Cytotoxic T Lymphocyte Antigen 4
PD1	Programmed cell Death 1
PD-L1	PD1 Ligand 1
ECM	Extracellular Matrix
US FDA	United States Food and Drug Administration
NSCLC	Non-Small-Cell Lung Cancer
MHC	Major Histocompatibility Complex
Mut/Mb	Mutations per coding genomic region analyzed
TMB	Tumor Mutational Burden
TMB-H	High Tumor Mutational Burden
TCGA	The Cancer Genome Atlas
WES	Whole Exome Sequencing
NGS	Next-Generation-Sequencing
F1CDx	FoundationOne CDx
MSK-IMPACT	Memorial Sloan Kettering Cancer Center’s Integrated Mutation Profiling of Actionable Cancer Targets
FoundationACT	Assay for Circulation Tumor DNA
MSI	Microsatellite Instability
dMMR	Defective DNA mismatch repair
MSI-H	High MSI
GEP	Gene Expression Profiling
cDNA	Complementary DNA
RNA-seq	RNA Sequencing
DGE	Differential Gene Expression
GSEA	Gene Set Enrichment Analysis
WGCNA	Weighted Gene Co-expression Network Analysis
TIS	Tumor Inflammation Signature
FFPE	Formalin-Fixed Paraffin-Embedded
mRNA	Messenger RNA
scRNA-seq	Single Cell RNA-seq
DEPArray	Di-Electro-Phoretic Array
STTs	Spatial Transcriptomic Technologies
DSP	Digital Spatial Profiling
ROI	Regions of Interest
STEREO-seq	SpaTial Enhanced REsolution Omics-sequencing
DNB	DNA nanoball
PDAC	Pancreatic Ductal Adenocarcinoma
CSCC	Cervical Squamous Cell Carcinoma
CAFs	Cancer-Associated Fibroblasts
HPV	Human Papillomavirus
TGF-β	Transforming Growth Factor β